These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9332325)

  • 21. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.
    Dalle Carbonare L; Valenti MT; Bertoldo F; Fracalossi A; Balducci E; Azzarello G; Vinante O; Lo Cascio V
    Aging Clin Exp Res; 2007 Apr; 19(2):91-6. PubMed ID: 17446718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
    Manzano-Moreno FJ; Ramos-Torrecillas J; De Luna-Bertos E; Ruiz C; García-Martínez O
    J Craniomaxillofac Surg; 2015 Apr; 43(3):396-401. PubMed ID: 25614214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesic effect of bisphosphonates in mice.
    Bonabello A; Galmozzi MR; Bruzzese T; Zara GP
    Pain; 2001 Apr; 91(3):269-275. PubMed ID: 11275384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment.
    Derenne S; Amiot M; Barillé S; Collette M; Robillard N; Berthaud P; Harousseau JL; Bataille R
    J Bone Miner Res; 1999 Dec; 14(12):2048-56. PubMed ID: 10620064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.
    Kunzmann V; Bauer E; Feurle J; Weissinger F; Tony HP; Wilhelm M
    Blood; 2000 Jul; 96(2):384-92. PubMed ID: 10887096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonate therapy in multiple myeloma.
    Laakso M; Jantunen E
    Acta Oncol; 1996; 35 Suppl 5():55-6. PubMed ID: 9142966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of clodronate and pamidronate on splenic and hepatic phagocytic cells of mice.
    Mönkkönen J; van Rooijen N; Ylitalo P
    Pharmacol Toxicol; 1991 Apr; 68(4):284-6. PubMed ID: 1830965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bisphosphonates on the rapidly growing male murine skeleton.
    Zhu ED; Louis L; Brooks DJ; Bouxsein ML; Demay MB
    Endocrinology; 2014 Apr; 155(4):1188-96. PubMed ID: 24422540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
    Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S
    Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro.
    Riebeling C; Forsea AM; Raisova M; Orfanos CE; Geilen CC
    Br J Cancer; 2002 Jul; 87(3):366-71. PubMed ID: 12177810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
    Mackie PS; Fisher JL; Zhou H; Choong PF
    Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Frith JC; Rogers MJ
    J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of bisphosphonates on breast cancer cell lines.
    Verdijk R; Franke HR; Wolbers F; Vermes I
    Cancer Lett; 2007 Feb; 246(1-2):308-12. PubMed ID: 16621245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro.
    Ylitalo R; Kalliovalkama J; Wu X; Kankaanranta H; Salenius JP; Sisto T; Lähteenmäki T; Ylitalo P; Pörsti I
    Pharmacol Toxicol; 1998 Sep; 83(3):125-31. PubMed ID: 9783331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
    Fromigué O; Body JJ
    J Endocrinol Invest; 2002 Jun; 25(6):539-46. PubMed ID: 12109626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
    Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes.
    Hagelauer N; Pabst AM; Ziebart T; Ulbrich H; Walter C
    Clin Oral Investig; 2015 Jan; 19(1):139-48. PubMed ID: 24668343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.